ALT is considered as an Indicator of Liver Disease that could globally be used like a valuable screening test for inapparent liver disease, such as asymptomatic viral hepatitis and non-alcoholic fatty liver disease, that still remains largely undiagnosed worldwide [20, 21]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.